Literature DB >> 11772359

Instrumentation and methodology for quantitative pre-clinical imaging studies.

S R Meikle1, S Eberl, H Iida.   

Abstract

Radiotracer imaging studies performed on animals have the potential to play a major role in pharmaceutical development, pharmacology studies and basic biochemistry research. Recent developments in instrumentation and imaging methodology make it possible to image and quantify the kinetics of radiolabelled pharmaceuticals in a wide range of animal models from rodents to non-human primates. This article reviews the developments which have led to the current state-of-the-art, including advances in detector technologies, image reconstruction and tracer kinetic modelling. The practical issues specific to animal imaging studies are also discussed. With appropriate instrumentation and rigorous methodology, quantitative pre-clinical imaging has an important role to play in drug development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11772359     DOI: 10.2174/1381612013396961

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  3 in total

1.  A new reconstruction strategy for image improvement in pinhole SPECT.

Authors:  Tsutomu Zeniya; Hiroshi Watabe; Toshiyuki Aoi; Kyeong Min Kim; Noboru Teramoto; Takuya Hayashi; Antti Sohlberg; Hiroyuki Kudo; Hidehiro Iida
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-17       Impact factor: 9.236

2.  Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice.

Authors:  Samanta Etel Treiger Borborema; João Alberto Osso; Heitor Franco de Andrade; Nanci do Nascimento
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-08       Impact factor: 2.743

Review 3.  Spectral Analysis of Dynamic PET Studies: A Review of 20 Years of Method Developments and Applications.

Authors:  Mattia Veronese; Gaia Rizzo; Alessandra Bertoldo; Federico E Turkheimer
Journal:  Comput Math Methods Med       Date:  2016-12-05       Impact factor: 2.238

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.